Generation and characterization of mouse hybridomas secreting monoclonal antibodies specific for human lgG3
AJMB-Avicenna Journal of Medical Biotechnology. 2009; 1 (1): 19-26
in En
| IMEMR
| ID: emr-90808
Responsible library:
EMRO
ABSTRACT
Mammalians express several subclasses of the IgG molecule. In human being there are four homologous IgG subclasses, each of which is structurally unique and has different functions. Quantification of IgG subclasses is fundamental to clinical assessment and diagnosis of many diseases as such assessments depends on the availability of subclassspecific antibodies [Abs], particularly monoclonal antibodies [MAbs]. In the present study, we produced and characterized two murine MAbs specific for human lgG3 molecule. These MAbs were obtained by the fusion of myeloma cells with splenocytes from Balb/c mice immunized with heavy chain of a human IgG3 myeloma protein. Fused cells were selected in, hypoxanthine, aminopterine and thymidine [HAT] medium and cloned by limiting dilution assay. Ab-secreting cells were screened by enzyme-linked immunosorbent assay [ELISA] and the specificity of secreted MAbs was further analyzed, using a panel of purified myeloma proteins by ELISA and immunoblotting. Two stable hybridomas designated 1F18G7 and 1F18A11 were obtained secreting MAbs specific for Fc fragment of human IgG3. None of these MAbs showed cross-reactivity with other immunoglobulin isotypes derived from human and nine other animals, except 1F18A11 which displayed a weak cross-reactivity with only dog serum. Immunoblotting results indicate that these MAbs react with linear epitope [s] located in the heavy chain of human IgG3 molecules. The affinity constant of 1F18G7 and 1F18A11 MAbs was found to be 0.81x10[9] Mol[-1] and 0.7x10[9] Mol[-1], respectively, as measured by ELISA. These two MAbs with relatively high affinity can be useful tools for quantification of IgG3 subclass levels in human serum
Search on Google
Index:
IMEMR
Main subject:
Immunoglobulin G
/
Enzyme-Linked Immunosorbent Assay
/
Immunoblotting
/
Hybridomas
Limits:
Animals
/
Humans
Language:
En
Journal:
Avicenna J. Med. Biotechnol.
Year:
2009